The experimental models of parkinson's disease in animals

被引:0
|
作者
Grigoryan, G.A. [1 ]
Bazyan, A.S. [1 ]
机构
[1] Institute of Higher Nervous Activity and Neurophysiology, RAN, Moscow
来源
Uspekhi Fiziologicheskikh Nauk | 2007年 / 38卷 / 04期
关键词
Nigrostriatal dopaminergic system - Sporadic form - Toxic protein;
D O I
暂无
中图分类号
学科分类号
摘要
The current review describes the modern Parkinson's disease models in animals, their advantages, limitations and disadvantages. It was noted that the most widespread up-to-date models based on etiology of the Parkinson's disease. Although toxins mostly produce the Parkinson's disease, a study of involved genes allows investigating not only inherited but also sporadic (not inherited) forms of disease since the same genes are involved in both cases. Mutations of genes lead to formation of mutant toxic proteins, which produce a death of the specialized neurons of the nigrostriatal dopaminergic system and the development of Parkinson's disease. A significant place in the review takes a description of characteristics of the toxic models produced by 6-OHDA, MPTP and rotenone, their similarities and differences in pathogenetic mechanisms of the Parkinson's disease development. On the basis of the considered experimental models of Parkinson's disease a conclusion has been done that none of these models may in full and adequate scale imitate the entire clinical, pathophysiological, morphological, biochemical and other aspects of the Parkinson's disease development.
引用
收藏
页码:80 / 88
相关论文
共 50 条
  • [1] Experimental models of Parkinson's disease
    Jenner, P
    PARKINSON'S DISEASE, 2002, 1 : 39 - 50
  • [2] Experimental models of Parkinson's disease
    M. Flint Beal
    Nature Reviews Neuroscience, 2001, 2 : 325 - 332
  • [3] Experimental models of Parkinson's disease
    Beal, MF
    NATURE REVIEWS NEUROSCIENCE, 2001, 2 (05) : 325 - 332
  • [4] Parkinson's disease: experimental models and reality
    Jiang, Peizhou
    Dickson, Dennis W.
    ACTA NEUROPATHOLOGICA, 2018, 135 (01) : 13 - 32
  • [5] Parkinson’s disease: experimental models and reality
    Peizhou Jiang
    Dennis W. Dickson
    Acta Neuropathologica, 2018, 135 : 13 - 32
  • [6] Comprehensive Perspectives on Experimental Models for Parkinson's Disease
    Ke, Minjing
    Chong, Cheong-Meng
    Zhu, Qi
    Zhang, Ke
    Cai, Cui-Zan
    Lu, Jia-Hong
    Qin, Dajiang
    Su, Huanxing
    AGING AND DISEASE, 2021, 12 (01): : 223 - 246
  • [7] Nonmotor Symptoms in Experimental Models of Parkinson's Disease
    Titova, Nataliya
    Schapira, Anthony H. V.
    Chaudhuri, K. Ray
    Qamar, Mubasher A.
    Katunina, Elena
    Jenner, Peter
    NONMOTOR PARKINSON'S: THE HIDDEN FACE: THE MANY HIDDEN FACES, 2017, 133 : 63 - 89
  • [8] Experimental Animal Models of Prodromal Parkinson's Disease
    Yamakado, Hodaka
    Takahashi, Ryosuke
    JOURNAL OF PARKINSONS DISEASE, 2024, 14 : S369 - S379
  • [9] Parkinson's disease: Experimental models and therapy - Preface
    Riederer, P
    Wesemann, W
    JOURNAL OF NEURAL TRANSMISSION-SUPPLEMENT, 1995, (46): : R5 - R7
  • [10] Fear Memory in Experimental Models of Parkinson's Disease
    Timofeeva, E. A.
    Dubrovina, N. I.
    Tikhonova, M. A.
    Amstislavskaya, T. G.
    ADVANCES IN GERONTOLOGY, 2024, 14 (01) : 1 - 13